Kailera Therapeutics is trading 4.47% lower at $11.45; the catalyst remains unconfirmed.
- The shares fell from the September 24 close of $11.98.
- No new company-specific announcement dated September 25, 2026, was identified; the latest listed release was its September 16 investor-conference notice.
- The broader market is modestly higher, with no clear evidence that today’s decline is following overall index direction.